ORIGINAL RESEARCH
Accepted on 26 Sep 2025
Glutaredoxin2 reduces age-associated B cell differentiation through maintaining redox homeostasis
doi 10.3389/fphar.2025.1593816
- 408 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Advances in Redox System Pharmacology for Treating Resistant Diseases
Advances in Redox System Pharmacology for Treating Resistant Diseases
340
Total downloads
3,313
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: